Dual mechanistic TRAIL nanocarrier based on PEGylated heparin taurocholate and protamine which exerts both pro-apoptotic and anti-angiogenic effects-Reference-Cited by-同舟云学术

Dual mechanistic TRAIL nanocarrier based on PEGylated heparin taurocholate and protamine which exerts both pro-apoptotic and anti-angiogenic effects

Published:2021-08 Issue: Volume:336 Page:181-191
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Choi Jeong Uk,Kim Ji-young,Chung Seung Woo,Lee Na Kyeong,Park Jooho,Kweon Seho,Cho Young Seok,Kim Ha Rin,Lim Sung Mook,Park Jin Woo,Lee Kang Choon,Byun Youngro

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference37 articles.

1. Nanocarriers for TRAIL delivery: driving TRAIL back on track for cancer therapy;Wu;Nanoscale,2017

2. To kill a tumor cell: the potential of proapoptotic receptor agonists;Ashkenazi;J. Clin. Invest.,2008

3. Safety and antitumor activity of recombinant soluble Apo2 ligand;Ashkenazi;J. Clin. Invest.,1999

4. The TRAIL apoptotic pathway in cancer onset, progression and therapy;Johnstone;Nat. Rev. Cancer,2008

5. Targeting TRAIL in the treatment of cancer: new developments;Lim;Expert Opin. Ther. Targets,2015

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor targeting in situ aggregation of nanoparticle-to-nanoparticle strategy to simultaneously induce ferroptosis and immunogenic cell death using complementary heparin and protamine molecules;Nano Today;2024-08

2. Stealth Nanocarriers in Cancer Therapy: a Comprehensive Review of Design, Functionality, and Clinical Applications;AAPS PharmSciTech;2024-06-18

3. Effect of novel anti-tumor and anti-angiogenesis drug taurolactone on angiogenic factor AGGF1 and angiogenesis mimicry in patients with hepatocellular carcinoma;BMC Cancer;2024-05-21

4. Advances in tumor nanotechnology: theragnostic implications in tumors via targeting regulated cell death;Apoptosis;2023-05-15

5. Polysaccharide-based nanocarriers for efficient transvascular drug delivery;Journal of Controlled Release;2023-02